MASIMO CORP (MASI) Stock Fundamental Analysis
NASDAQ:MASI - Nasdaq - US5747951003 - Common Stock - Currency: USD
Overall MASI gets a fundamental rating of 4 out of 10. We evaluated MASI against 189 industry peers in the Health Care Equipment & Supplies industry. MASI has an average financial health and profitability rating. MASI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MASI had positive earnings in the past year.
MASI had a positive operating cash flow in the past year.
MASI had positive earnings in 4 of the past 5 years.
In the past 5 years MASI always reported a positive cash flow from operatings.
1.2 Ratios
MASI has a Return On Assets (-21.56%) which is comparable to the rest of the industry.
The Return On Equity of MASI (-52.25%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.74%, MASI is doing good in the industry, outperforming 73.55% of the companies in the same industry.
MASI had an Average Return On Invested Capital over the past 3 years of 4.58%. This is below the industry average of 7.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.56% | ||
| ROE | -52.25% | ||
| ROIC | 3.74% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.58%
ROIC(5y)8.17%
1.3 Margins
MASI has a better Operating Margin (4.19%) than 70.37% of its industry peers.
In the last couple of years the Operating Margin of MASI has declined.
The Gross Margin of MASI (50.50%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MASI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.19% | ||
| PM (TTM) | N/A | ||
| GM | 50.5% |
OM growth 3Y-55.93%
OM growth 5Y-39.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
2. Health
2.1 Basic Checks
MASI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MASI has been increased compared to 1 year ago.
MASI has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for MASI has been reduced compared to a year ago.
2.2 Solvency
MASI has an Altman-Z score of 5.88. This indicates that MASI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MASI (5.88) is better than 79.89% of its industry peers.
MASI has a debt to FCF ratio of 4.48. This is a neutral value as MASI would need 4.48 years to pay back of all of its debts.
MASI's Debt to FCF ratio of 4.48 is amongst the best of the industry. MASI outperforms 82.54% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that MASI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.67, MASI is not doing good in the industry: 67.20% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 4.48 | ||
| Altman-Z | 5.88 |
ROIC/WACC0.43
WACC8.61%
2.3 Liquidity
MASI has a Current Ratio of 2.17. This indicates that MASI is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.17, MASI is not doing good in the industry: 62.43% of the companies in the same industry are doing better.
A Quick Ratio of 1.62 indicates that MASI should not have too much problems paying its short term obligations.
MASI's Quick ratio of 1.62 is in line compared to the rest of the industry. MASI outperforms 42.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
MASI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.12%, which is quite impressive.
The Earnings Per Share has been growing slightly by 5.86% on average over the past years.
MASI shows a decrease in Revenue. In the last year, the revenue decreased by -0.12%.
The Revenue has been growing by 17.43% on average over the past years. This is quite good.
EPS 1Y (TTM)58.12%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%76.62%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-24.51%
3.2 Future
Based on estimates for the next years, MASI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
Based on estimates for the next years, MASI will show a decrease in Revenue. The Revenue will decrease by -0.42% on average per year.
EPS Next Y22.78%
EPS Next 2Y15.37%
EPS Next 3Y15.06%
EPS Next 5Y12.14%
Revenue Next Year-27.16%
Revenue Next 2Y-11.41%
Revenue Next 3Y-5.32%
Revenue Next 5Y-0.42%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
MASI is valuated quite expensively with a Price/Earnings ratio of 32.07.
Based on the Price/Earnings ratio, MASI is valued a bit cheaper than 72.49% of the companies in the same industry.
MASI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.60.
The Price/Forward Earnings ratio is 27.42, which means the current valuation is very expensive for MASI.
MASI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MASI is cheaper than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, MASI is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.07 | ||
| Fwd PE | 27.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MASI is valued a bit cheaper than 67.72% of the companies in the same industry.
MASI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MASI is cheaper than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.08 | ||
| EV/EBITDA | 52.7 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MASI's earnings are expected to grow with 15.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)5.48
EPS Next 2Y15.37%
EPS Next 3Y15.06%
5. Dividend
5.1 Amount
No dividends for MASI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
156.17
+1.04 (+0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.77%
Inst Owner Change5.45%
Ins Owners0.15%
Ins Owner Change3.35%
Market Cap8.44B
Analysts81.33
Price Target199.61 (27.82%)
Short Float %5.19%
Short Ratio3.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.57%
Min EPS beat(2)10.25%
Max EPS beat(2)14.9%
EPS beat(4)4
Avg EPS beat(4)12.57%
Min EPS beat(4)10.25%
Max EPS beat(4)14.9%
EPS beat(8)8
Avg EPS beat(8)11.42%
EPS beat(12)12
Avg EPS beat(12)10.04%
EPS beat(16)16
Avg EPS beat(16)8.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.68%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)-0.59%
Revenue beat(8)0
Avg Revenue beat(8)-2.4%
Revenue beat(12)3
Avg Revenue beat(12)-1.34%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)1%
PT rev (3m)6.13%
EPS NQ rev (1m)-0.69%
EPS NQ rev (3m)17.28%
EPS NY rev (1m)-1.8%
EPS NY rev (3m)9.79%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-25.77%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)-28.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.07 | ||
| Fwd PE | 27.42 | ||
| P/S | 4.28 | ||
| P/FCF | 58.08 | ||
| P/OCF | 46.45 | ||
| P/B | 8.92 | ||
| P/tB | 10.72 | ||
| EV/EBITDA | 52.7 |
EPS(TTM)4.87
EY3.12%
EPS(NY)5.7
Fwd EY3.65%
FCF(TTM)2.69
FCFY1.72%
OCF(TTM)3.36
OCFY2.15%
SpS36.52
BVpS17.51
TBVpS14.57
PEG (NY)1.41
PEG (5Y)5.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.56% | ||
| ROE | -52.25% | ||
| ROCE | 4.73% | ||
| ROIC | 3.74% | ||
| ROICexc | 4.04% | ||
| ROICexgc | 4.48% | ||
| OM | 4.19% | ||
| PM (TTM) | N/A | ||
| GM | 50.5% | ||
| FCFM | 7.36% |
ROA(3y)-1.49%
ROA(5y)4.35%
ROE(3y)-4.1%
ROE(5y)3.92%
ROIC(3y)4.58%
ROIC(5y)8.17%
ROICexc(3y)4.95%
ROICexc(5y)12.77%
ROICexgc(3y)9.27%
ROICexgc(5y)17.89%
ROCE(3y)5.8%
ROCE(5y)10.34%
ROICexcg growth 3Y-55.81%
ROICexcg growth 5Y-40.49%
ROICexc growth 3Y-58.97%
ROICexc growth 5Y-44.46%
OM growth 3Y-55.93%
OM growth 5Y-39.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.74%
GM growth 5Y-6.5%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 4.48 | ||
| Debt/EBITDA | 3.74 | ||
| Cap/Depr | 41.7% | ||
| Cap/Sales | 1.84% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 106.88% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 5.88 |
F-Score5
WACC8.61%
ROIC/WACC0.43
Cap/Depr(3y)60.07%
Cap/Depr(5y)110.25%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.12%
EPS 3Y2.37%
EPS 5Y5.86%
EPS Q2Q%76.62%
EPS Next Y22.78%
EPS Next 2Y15.37%
EPS Next 3Y15.06%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y19.12%
Revenue growth 5Y17.43%
Sales Q2Q%-24.51%
Revenue Next Year-27.16%
Revenue Next 2Y-11.41%
Revenue Next 3Y-5.32%
Revenue Next 5Y-0.42%
EBIT growth 1Y-49.63%
EBIT growth 3Y-47.5%
EBIT growth 5Y-29%
EBIT Next Year38.91%
EBIT Next 3Y15.22%
EBIT Next 5Y12.23%
FCF growth 1Y422.89%
FCF growth 3Y-14.18%
FCF growth 5Y-0.52%
OCF growth 1Y2653.03%
OCF growth 3Y-9.48%
OCF growth 5Y-2.39%